Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Bump from v3.0.1 to v3.0.2 and removal of the Back to Top link; no substantive changes to core content, pricing, stock, or time slots.
    Difference
    0.1%
    Check dated 2025-09-14T23:06:25.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T19:46:36.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while key terms related to pembrolizumab and various pharmacological classifications have been removed.
    Difference
    0.9%
    Check dated 2025-08-31T12:30:10.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T05:07:53.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:52:53.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and the previous version 2.16.8 has been removed. Additionally, a service alert regarding planned maintenance has been deleted.
    Difference
    0.7%
    Check dated 2025-08-02T19:43:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.